What’s New in SKIN?

Featuring Roger Ceilley, MD |

Clinical Professor of Dermatology
University of Iowa School of Medicine
Des Moines, IA

| Published October 29, 2024

Dr Roger Ceilley provided a comprehensive overview of the past year for SKIN: The Journal of Cutaneous Medicine, highlighting the journal’s rapid growth and valuable contributions to the field of dermatology. As a peer-reviewed, open-access, and online-only journal, SKIN has surpassed 1.4 million reads since its launch while expanding its editorial team and fellow/medical student board and steadily increasing its monthly readership. 

Dr Ceilley also addressed significant advancements in dermatology research published in SKIN. He highlighted new consensus statements on psoriasis, which underscore the systemic impact of the disease and emphasize the importance of early intervention for patients with mild-to-moderate psoriasis. Additionally, he discussed the rising influence of artificial intelligence (AI) in dermatology, while drawing attention to the lack of pediatric-focused AI research and the potential for AI to improve access to care for underserved populations. 

In terms of therapeutic advancements, SKIN published an expert consensus report on bimekizumab, which demonstrated faster and more effective results compared to other biologics, though with a higher risk of oral candidiasis. 

Dr Ceilley also introduced a new section in the journal dedicated to medical education in dermatology. Recent articles in this section have explored topics like the diagnostic confidence of dermatology residents when treating patients with skin of color. Additionally, he highlighted one of the journal’s most popular sections, “SKINmages: Clinical Images in Dermatology,” which invites authors to submit rare and intriguing dermatologic observations. Several compelling images and corresponding cases were shared as examples of this unique feature.

Loading...

Related Media

Powered by Polaris TM
Dermsquared

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved